Home › Companies › STRUCTURE THERAPEUTICS INC. › 2023-2024
At STRUCTURE THERAPEUTICS INC.'s shareholder meeting held June 25, 2024, in the 2023-2024 proxy season, 50 asset managers reported how they voted in their SEC Form N-PX filings, covering 241 separate fund positions. Their filings are grouped here into 2 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. STRUCTURE THERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Election of the nominee for Class I director named below to serve until the 2027 annual general… — the reporting funds cast 95% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and STRUCTURE THERAPEUTICS INC.’s Form 8-K, filed June 27, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 25, 2024: 2 items on STRUCTURE THERAPEUTICS INC.’s Form 8-K, filed June 27, 2024: 1 approved · 1 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore STRUCTURE THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are STRUCTURE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 27, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. Election of Director Sharon Tetlow | 117,225,817 | 12,607,569 | 111,111 | -- | 0 | 90% | Not verified | — |
| 2. Ratification of Appointment of Independent Registered Public Accounting Firm | 129,906,202 | 32,139 | 6,156 | -- | 0 | 99.9% | Approved | — |
Source: STRUCTURE THERAPEUTICS INC., Form 8-K, filed with the SEC on June 27, 2024 — read the filing on EDGAR.
Each item below shows how the 50 asset managers that disclosed a STRUCTURE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of STRUCTURE THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 6 wordings of this item as funds reported it.
95% of fund votes cast · no official result
Description as filed by funds: Election of the nominee for Class I director named below to serve until the 2027 annual general meeting of shareholders and until her successor is duly elected and qualified, or until her earlier death, resignation or removal: Sharon Tetlow
The 50 asset managers below reported 16,138,510 for, 762,218 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,319,241 | 0 | 0 | 0 | For |
| Capital Group | 3,230,187 | 0 | 0 | 0 | For |
| Fidelity | 2,334,447 | 0 | 0 | 0 | For |
| Federated Hermes | 2,257,206 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,045,169 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 711,709 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 425,898 | 0 | 0 | 0 | For |
| ALGER FUNDS | 0 | 336,729 | 0 | 0 | Against |
| FRANKLIN STRATEGIC SERIES | 272,664 | 0 | 0 | 0 | For |
| Invesco | 0 | 257,743 | 0 | 0 | Against |
| DRIEHAUS MUTUAL FUNDS | 255,222 | 0 | 0 | 0 | For |
| Hartford | 243,440 | 0 | 0 | 0 | For |
| BlackRock | 230,773 | 0 | 0 | 0 | For |
| American Century | 224,111 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 86,001 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 0 | 76,339 | 0 | 0 | Against |
| John Hancock | 72,764 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 58,000 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 56,551 | 0 | 0 | 0 | For |
| Northwestern Mutual | 41,759 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 38,743 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 35,494 | 0 | 0 | 0 | For |
| MassMutual | 11,650 | 20,722 | 0 | 0 | Mixed |
| Allspring | 30,641 | 0 | 0 | 0 | For |
| Listed Funds Trust | 29,336 | 0 | 0 | 0 | For |
Showing the 25 largest of 50 asset managers. All 50 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
STRUCTURE THERAPEUTICS INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm”): 129,906,202 for, 32,139 against — passed, per its Form 8-K filed June 27, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The Company's shareholders ratified the appointment by the Audit Committee (the "Audit Committee") of the Company's Board of Directors (the "Board") of Ernst & Young LLP as the Company's independent registered …”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 50 asset managers below reported 16,898,581 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,319,241 | 0 | 0 | 0 | For |
| Capital Group | 3,230,187 | 0 | 0 | 0 | For |
| Fidelity | 2,334,447 | 0 | 0 | 0 | For |
| Federated Hermes | 2,257,206 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,045,169 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 711,709 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 425,898 | 0 | 0 | 0 | For |
| ALGER FUNDS | 336,729 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 272,664 | 0 | 0 | 0 | For |
| Invesco | 257,743 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 255,222 | 0 | 0 | 0 | For |
| Hartford | 243,440 | 0 | 0 | 0 | For |
| BlackRock | 230,773 | 0 | 0 | 0 | For |
| American Century | 224,111 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 86,001 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 76,339 | 0 | 0 | 0 | For |
| John Hancock | 72,764 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 58,000 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 56,551 | 0 | 0 | 0 | For |
| Northwestern Mutual | 41,759 | 0 | 0 | 0 | For |
| MML SERIES INVESTMENT FUND | 38,743 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 35,494 | 0 | 0 | 0 | For |
| MassMutual | 32,372 | 0 | 0 | 0 | For |
| Allspring | 30,641 | 0 | 0 | 0 | For |
| Listed Funds Trust | 29,336 | 0 | 0 | 0 | For |
Showing the 25 largest of 50 asset managers. All 50 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 139,863,370 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 2.37% |
| 2 | Capital Group | 2.31% |
| 3 | Fidelity | 1.67% |
| 4 | Federated Hermes | 1.61% |
| 5 | T. Rowe Price | 1.46% |
| 6 | JANUS INVESTMENT FUND | 0.51% |
| 7 | Bridge Builder Trust | 0.30% |
| 8 | ALGER FUNDS | 0.24% |
| 9 | FRANKLIN STRATEGIC SERIES | 0.19% |
| 10 | Invesco | 0.18% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR LLC | 12.42% | DEF14A |
| Entities affiliated with Wellington Management Group LLP | 9.38% | DEF14A |
| Deep Track Capital, LP | 8.79% | 13G |
| Avoro Capital Advisors LLC | 5.00% | DEF14A |
| Capital Research Global Investors | 4.64% | 13G |
| Wellington Management | 4.17% | 13F |
| FMR (Fidelity) | 3.75% | 13F |
| JANUS HENDERSON GROUP PLC | 3.11% | 13G |
| Ramy Farid, Ph.D. | 2.92% | DEF14A |
| Raymond Stevens, Ph.D. | 2.65% | DEF14A |
Percentages above are of 139,863,370 shares outstanding, as reported by STRUCTURE THERAPEUTICS INC. on its Form 10-Q dated April 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from STRUCTURE THERAPEUTICS INC.’s 10-Q dated April 30, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
STRUCTURE THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “STRUCTURE THERAPEUTICS (GPCR) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/structure-therapeutics-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.